
Kate Hanneman
Site Director, Women’s College Hospital
Dr. Kate Hanneman completed medical school and diagnostic radiology residency at the University of Toronto, a cardiovascular imaging fellowship at Stanford University, and a Master’s degree in Public Health in Epidemiology at Harvard University.
She is currently appointed as an Associate Professor of Medical Imaging at the University of Toronto. Her clinical work focuses on cardiac CT and MRI, in addition to chest imaging. As a Clinician Scientist, she leads an active research program focused on improving health outcomes for patients with cardiomyopathies using cardiac imaging.
Since her appointment to JDMI in 2015, she has received over $1.4 million in peer-reviewed grant funding from agencies including CIHR.
- Magnetic Resonance Imaging of Cardiovascular Manifestations Following COVID-19
Globally, over 650 million people have had COVID-19 due to infection with the SARS-Cov-2 virus. Cardiac complications in the acute infectious and […]
- Cardiac Magnetic Resonance Imaging T1 and T2 Mapping in Systemic Lupus Erythematosus in Relation to Antimalarial Treatment
CONCLUSIONS: The relationship between T1 and AM treatment duration differed between groups. Native T1 decreases with longer treatment in patients […]
- Myocarditis Following COVID-19 Vaccination
Myocarditis is an established but rare adverse event following administration of messenger RNA-based coronavirus disease 2019 (COVID-19) vaccines and […]
- Prognostic Value of Cardiac MRI and FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis
Background There is no consensus regarding the relative prognostic value of cardiac MRI and fluorodeoxyglucose (FDG) PET in cardiac sarcoidosis. […]
- Interpretable machine learning for automated left ventricular scar quantification in hypertrophic cardiomyopathy patients
Scar quantification on cardiovascular magnetic resonance (CMR) late gadolinium enhancement (LGE) images is important in risk stratifying patients […]
- Cardiac Magnetic Resonance Imaging and Clinical Follow-up in Antimalarial-induced Cardiomyopathy in Patients With Systemic Lupus Erythematosus
Antimalarial-induced cardiomyopathy is under-recognized in clinical practice and there is limited data on the evolution of cardiac imaging […]
- The updated CADS-RADS 2.0: Changes, challenges and considerations for implementation-commentary by North American Society of Cardiovascular Imaging (NASCI)
No abstract
- Registry of Aortic Diseases to Model Adverse Events and Progression (ROADMAP) in Uncomplicated Type B Aortic Dissection: Study Design and Rationale
CONCLUSION: This study will show whether a recent clinical and imaging-based risk prediction model for patients with uTBAD can be generalized to a […]
- NASCI young investigator awards 2022
Each year, the North American Society of Cardiovascular Imaging (NASCI) selects the Young Investigator Awards, which are amongst the top abstracts […]
- Cardiac Link: a retrospective cohort study evaluating a clinical pathway for expedited cardiology referral
BACKGROUND: Outpatients presenting with chest pain often face long wait times for cardiology consultation and subsequent investigation for […]
- Letter from the Guest Editor - Aortic and Vascular Imaging
No abstract
- Association of Pectus Excavatum With Ventricular Remodelling and Mitral Valve Abnormalities in Marfan Syndrome
Background: Marfan syndrome (MFS) is an inherited connective tissue disorder. Pectus excavatum (PEX) is common in MFS. The purpose was to evaluate […]
- Cardiac Imaging in Myocarditis: Current Evidence and Future Directions
Myocarditis is defined as a non-ischemic inflammatory disease of the myocardium. It remains a challenge to diagnose given non-specific symptoms and […]
- Inter-observer variability of expert-derived morphologic risk predictors in aortic dissection
CONCLUSIONS: Manual morphologic feature measurements on CTA images can be optimized resulting in improved inter-observer reliability. This is […]
- Myocarditis Following COVID-19 Vaccination
Myocarditis is an established but rare adverse event following administration of messenger RNA-based coronavirus disease 2019 (COVID-19) vaccines and […]
- Clinical Impact of Cardiac MRI T1 and T2 Parametric Mapping in Patients with Suspected Cardiomyopathy
Background There are limited data on the incremental value of parametric mapping compared with core cardiac MRI protocols for suspected […]
- Temporal Changes in Cardiac Morphology and Its Relationship with Clinical Characteristics and Outcomes in Patients with Hypertrophic Cardiomyopathy
In this study, we aimed to assess a large cohort of nonapical hypertrophic cardiomyopathy (HC) patients who have undergone 2 serial cardiac magnetic […]
- Editorial for "Cardiac Magnetic Resonance Imaging Findings in COVID-19 Vaccine-Related Myocarditis: A Pooled Analysis of 468 Patients"
No abstract
- Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19
CONCLUSIONS: Cardiac diagnostic testing has yet to recover to prepandemic levels in lower-income countries. Worldwide, the decrease in standard […]
- Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis
Background There is limited consensus regarding the relative diagnostic performance of cardiac MRI and fluorodeoxyglucose (FDG) PET for cardiac […]
- Predefined and data driven CT densitometric features predict critical illness and hospital length of stay in COVID-19 patients
The aim of this study was to compare whole lung CT density histograms to predict critical illness outcome and hospital length of stay in a cohort of […]
- ACR Appropriateness Criteria® Dyspnea-Suspected Cardiac Origin (Ischemia Already Excluded): 2021 Update
Dyspnea is the symptom of perceived breathing discomfort and is commonly encountered in a variety of clinical settings. Cardiac etiologies of dyspnea […]
- Imaging of Myocarditis Following mRNA COVID-19 Booster Vaccination
Keywords: Echocardiography, MR-Functional Imaging, MRI, Cardiac Supplemental material is available for this article.
- Cardiac MRI and Clinical Follow-up in COVID-19 Vaccine-associated Myocarditis
No abstract
- MRI detection of suspected nasopharyngeal carcinoma: a systematic review and meta-analysis
CONCLUSION: This study demonstrates that MRI has a high pooled sensitivity, specificity, and negative predictive value for detection of NPC. MRI may […]
- Visual Ordinal Scoring of Coronary Artery Calcium on Contrast-Enhanced and Noncontrast Chest CT: A Retrospective Study of Diagnostic Performance and Prognostic Utility
BACKGROUND. Current guidelines recommend visual evaluation of coronary artery calcium (CAC) on all nongated noncontrast chest CT examinations. […]
- Statin Use for Primary Cardiovascular Disease Prevention Is Low in Inflammatory Arthritis
CONCLUSIONS: Statin therapy is suboptimal in IA despite a significant number of patients meeting indication based on lipoprotein thresholds or CAC […]
- Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies
BACKGROUND: Endothelial cell (EC) activation, endotheliitis, vascular permeability, and thrombosis have been observed in patients with severe […]
- Cardiac MRI of Hereditary Cardiomyopathy
Hereditary cardiomyopathy comprises a heterogeneous group of diseases of the cardiac muscle that are characterized by the presence of genetic […]
- Imaging and Surveillance of Chronic Aortic Dissection: A Scientific Statement From the American Heart Association
All patients surviving an acute aortic dissection require continued lifelong surveillance of their diseased aorta. Late complications, driven […]